USANA Health Sciences (NYSE:USNA) Sets New 52-Week Low – Should You Sell?

Shares of USANA Health Sciences, Inc. (NYSE:USNA) reached a new 52-week low during trading on Wednesday . The company traded as low as $30.16 and last traded at $30.32, with a volume of 5576 shares trading hands. The stock had previously closed at $30.97.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on USNA. StockNews.com upgraded USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research report on Saturday, December 28th. DA Davidson upped their target price on USANA Health Sciences from $35.00 to $38.00 and gave the company a “neutral” rating in a report on Thursday, January 2nd.

USANA Health Sciences Price Performance

The company has a market capitalization of $602.62 million, a PE ratio of 11.17, a P/E/G ratio of 0.84 and a beta of 0.87. The business’s 50 day simple moving average is $34.53 and its 200 day simple moving average is $37.24.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in USNA. Pzena Investment Management LLC increased its stake in USANA Health Sciences by 3.6% during the fourth quarter. Pzena Investment Management LLC now owns 1,087,076 shares of the company’s stock worth $39,015,000 after acquiring an additional 37,466 shares during the last quarter. Pacer Advisors Inc. increased its position in shares of USANA Health Sciences by 8.8% during the 4th quarter. Pacer Advisors Inc. now owns 592,001 shares of the company’s stock worth $21,247,000 after purchasing an additional 47,745 shares during the last quarter. State Street Corp increased its position in shares of USANA Health Sciences by 0.6% during the 3rd quarter. State Street Corp now owns 435,164 shares of the company’s stock worth $16,501,000 after purchasing an additional 2,782 shares during the last quarter. Geode Capital Management LLC raised its holdings in USANA Health Sciences by 1.6% in the 4th quarter. Geode Capital Management LLC now owns 301,949 shares of the company’s stock valued at $10,839,000 after buying an additional 4,829 shares during the period. Finally, American Century Companies Inc. lifted its position in USANA Health Sciences by 12.3% in the fourth quarter. American Century Companies Inc. now owns 233,797 shares of the company’s stock valued at $8,391,000 after buying an additional 25,522 shares during the last quarter. 54.25% of the stock is currently owned by institutional investors and hedge funds.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.